IDEXX Laboratories

IDEXX Laboratories

Yahoo Finance • 3 days ago

US Stock Market Today: S&P 500 Futures Slip On Firm Manufacturing And Jobs Focus

The Morning Bull - US Market Morning Update Tuesday, Nov, 3 2026 US stocks are set for a softer open, with sentiment pulled in two directions by competing signals on growth and inflation. Strong US manufacturing data is the main force sha... Full story

Yahoo Finance • 3 days ago

US Equity Markets Mixed as Technology Sell-Off Continues, Crude Oil Prices Dip

US equity indexes were mixed Monday amid declining crude oil prices and continued sell-off in the te Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • 3 days ago

Sector Update: Healthcare Stocks Ease Late Afternoon

Healthcare stocks eased late Monday afternoon with the NYSE Healthcare Index down 0.1% and the State Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • 4 days ago

Stocks making the biggest moves midday: Oracle, SpaceX, Tempus AI, Rivian & more

Check out some of the companies making the biggest moves midday: Oracle — The database software giant's stock slumped another 6% after the company filed plans Monday to issue new stock and more debt to finance its artificial intelligence b... Full story

Yahoo Finance • 4 days ago

Avantis U.S. Large Cap Value (AVLV) Adds Exxon Mobil and Qualcomm on Oct. 29

This article first appeared on GuruFocus. Avantis U.S. Large Cap Value ETF (AVLV) reported gross ETF activity of $740.5 million on Thursday, with $614.0 million net bought against $22.64 billion in assets. AVLV increased 173 positions and... Full story

Yahoo Finance • 15 days ago

IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth?

Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on Astute Optics - US's Substack. In this article, we will summarize the bulls' thesis on IDXX. IDEXX Laboratories, Inc.'s share was trading at $553.4... Full story

Yahoo Finance • 15 days ago

Goldman Sachs Sees a Shift in the Stock Market — and Names 2 Stocks to Buy Now

Long-term stock market performance depends on more than economic growth, interest rates, and corporate earnings. Broader trends that develop over many years can also create investment opportunities, particularly for companies positioned to... Full story

Yahoo Finance • 15 days ago

Is This the Right Time to Hold EW Stock in Your Portfolio?

Edwards Lifesciences EW sees Transcatheter Mitral and Tricuspid Therapies ("TMTT") momentum, fueled by PASCAL, EVOQUE and SAPIEN M3, supported by clinical evidence and broader market access. The company's Transcatheter Aortic Valve Replace... Full story

Yahoo Finance • 16 days ago

BSX Set to Report Q3 Earnings: Will MedSurg Strength Aid Performance?

Boston Scientific Corporation BSX is slated to report third-quarter 2026 results on Oct. 28, before the market opens. The renowned medical device manufacturer posted earnings per share (EPS) of 86 cents in the last reported quarter, which... Full story

Yahoo Finance • 16 days ago

Ecolab Gears Up to Report Q3 Results: How to Play the Stock?

Ecolab ECL is scheduled to release third-quarter 2026 results on Oct. 27, before the opening bell. In the last reported quarter, the company delivered earnings that surpassed the estimates by 0.48%. ECL's earnings beat estimates in three o... Full story

Yahoo Finance • 17 days ago

Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX

Investing.com -- Jefferies downgraded Zoetis and Elanco to Hold from Buy on Tuesday, warning that pricing power in animal health is at risk. The firm reiterated its Buy rating on IDEXX Laboratories. Still guessing which stocks will beat t... Full story

Yahoo Finance • 19 days ago

Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus

The S&P 500 Health Care Sector Index (XLV) gained 3% for the week.The top S&P 500 healthcare gainers and losers for the past week are as follows:TOP FIVE GAINERS: * Idexx Laboratories (IDXX [https://seekingalpha.com/symbol/IDXX]) +8.18%... Full story

Yahoo Finance • 2 months ago

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets

Key Points Interested in IDEXX Laboratories, Inc.? Here are five stocks we like better. IDEXX reaffirmed its long-term growth targets of more than 10% organic revenue growth and more than 15% EPS growth, supported by recurring-revenue mom... Full story

Yahoo Finance • 2 months ago

IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics

On September 16, IDEXX Laboratories (NASDAQ:IDXX) announced it had bought CoVetAI, a fast-growing veterinary software company whose tool listens during appointments and organizes what gets said and done. It sounds like a productivity gadge... Full story

Yahoo Finance • 2 months ago

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection

Expanded testing menu now detects more intestinal parasites during routine visits WESTBROOK, Maine, September 17, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announce... Full story

Yahoo Finance • 2 months ago

IDEXX Laboratories buys CoVetAI

[IDEXX Laboratories offices in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images IDEXX Laboratories (IDXX [https://seekingalpha.com/symbol/IDXX]) has acquired [https://seekingalpha.com/pr/20653060-idexx-laboratories-acq... Full story

Yahoo Finance • 2 months ago

Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?

Photo by Pexels on Pixabay If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying repl... Full story

Yahoo Finance • 3 months ago

IDEXX (IDXX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Officer - Andrew Emerson Vice President, Investor Relations - John Ravis... Full story

Yahoo Finance • 3 months ago

Catalyst Watch: Inflation reads, AMAT earnings, Google Pixel event, and MLB on Netflix

[Lower Manhattan Cityscape] Art Wager/E+ via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.... Full story

Yahoo Finance • 3 months ago

Idexx outlines 2026 revenue of $4.70B-$4.75B while targeting 5,500 inVue Dx placements

Earnings Call Insights: IDEXX Laboratories (IDXX) Q2 2026 MANAGEMENT VIEW * Andrew Emerson (Executive VP, CFO & Treasurer) said IDEXX delivered “approximately 10%” reported revenue growth and “9%” organic growth, driven by “over 10% or... Full story